Skip to content

Inspection Record

Huangshi Hygenic Material Medicine Co. — FDA 483 Findings

US FDAInspected 2024-08-30Published 2026-11-13 6 findingsStability and storageLaboratory and QC controlsEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Stability and storage

An adequate number of batches of each drug product are not tested nor are records of such data maintained to determine an appropriate expiration date.

2Laboratory and QC controls

Laboratory records do not include the initials or signature of a second person showing that the original records have been reviewed for accuracy, completeness and compliance with established standards.

3Laboratory and QC controls

Each batch of drug product required to be free of objectionable microorganisms is not tested through appropriate laboratory testing.

4Equipment and facility

Buildings used in the manufacturing and processing of a drug product are not maintained in a good state of repair.

5Equipment and facility

Equipment and utensils are not cleaned and maintained at appropmiate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

6Laboratory and QC controls

Laboratory records are deficient in that they do not include a statement of the results of tests and how they compare to the established specifications.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-11-13. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Huangshi Hygenic Material Medicine Co. company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.